Protagonist Therapeutics Inc. Shares Near 52-Week High - Market Mover

The shares closed 1.8% below its 52-week high of $31.58, with trading volume lower than its 30 day average

Mar 12, 2021 by Kwhen Finance Editors

Protagonist Therapeutics Inc. Shares Near 52-Week High - Market Mover
Protagonist Therapeutics Inc. shares closed today at 1.8% below its 52 week high of $31.58, giving the company a market cap of $1B. The stock is currently up 53.8% year-to-date, up 292.4% over the past 12 months, and up 165.0% over the past five years. This week, the Dow Jones Industrial Average rose 4.1%, and the S&P 500 rose 2.7%.

Trading Activity

  • Trading volume this week was 60.5% higher than the 20-day average.
  • Beta, a measure of the stock’s volatility relative to the overall market stands at 1.2.

Technical Indicators

  • The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
  • MACD, a trend-following momentum indicator, indicates an upward trend.
  • The stock closed below its Bollinger band, indicating it may be oversold.

Market Comparative Performance

  • The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis
  • The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis
  • The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and beats it on a 5 year basis
NameDoD %ΔYTD %Δ1 Yr %52-Week H %52-Week L %
Protagonist Therapeutics Inc.-0.253.8292.4-3.2476.8
Dow Jones Industrial Average0.97.644.4-0.882.1
S&P 500 Index0.15.449.0-0.981.9
Health Care0.21.231.3-4.660.1

Peer Group Comparative Performance

  • The company's stock price performance year-to-date lags the peer average by -8.6%
  • The company's stock price performance over the past 12 months beats the peer average by 106.1%
NameMKT CAP (USD)P/EYTD %Δ1 Yr %Δ52-Week H %52-Week L %
Protagonist Therapeutics Inc.PTGX053.8292.4-3.2476.8
Peer AvgN/A058.8141.9-26.5215.0
Ocular Therapeutix IncOCUL00.7339.7-25.7372.5
OncoCyte Corp.OCX0100.8129.7-29.2304.3
Oragenics Inc.OGEN0133.998.2-51.2183.3

This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.

Was this content valuable for you?

Tags: